EV
About
EVVIVAX is a biotechnology company that pursues the discovery and development of innovative therapeutic veterinary cancer vaccines based on viral vectors and DNA platform technologies. The company engineers the antigens and use combinations of different genetic immunization modalities (heterologous prime/boost) as a powerful approach to induce superior immune responses and achieve greater clinical efficacy. they also offer services such as electrochemotherapy, in vivo electroporation, genetic vaccine, electro-gene-transfer, and vet-eporatorTM. Its headquarters is located in Rome, Italy and was founded in 2016 by Luigi Aurisicchio.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 161 investors are based in Rome, Lazio, Italy.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Rome, Italy
Contact Information
linkedin.com/in/••••••••
Find more investors like EVVIVAX
Search Investors